Chapter 9 Quantification and structural elucidation of low quantities of radiolabeled metabolites using microplate scintillation counting (msc) techniques in conjunction with lc-ms

Progress in Pharmaceutical and Biomedical Analysis

Volumn 6, Issue C, 2005, Pages 195-223

  Zhu, Mingshe ^a   Zhang, Donglu ^a   Skiles, Gary L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957070673     PISSN: 14643456     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1464-3456(05)80011-0     Document Type: Article

References (35)

1. Lin J.H., and Lu A.Y.H. Role of pharmacokinetics and metabolism in drug discovery and development. Pharm. Rev. 49 (1997) 403-449
2. Tucker G.T., Houston J.B., and Huang S.-M. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus. Clin. Pharm. Ther. 70 (2001) 103-114
3. The European Agency for the Evaluation of Medicinal Products: Human Medicines Evaluation Unit, 1997. Note for Guidance on the Investigation of Drug Interactions. (CPMP/EW/560/95).
4. Baillie T.A., Cayen M.N., Fouda H., Gerson R.J., Green J.D., Grossman S.J., Klunk L.J., LeBlance B., Perkins D.G., and Shipley L.A. Contemporary issues in toxicology: drug metabolites in safety testing. Toxicol. Appl. Pharm. 182 (2002) 188-196
5. Lautala P., Ulmanen I., and Taskine J. Radiochemical high-performance liq-uid Chromatographic assay for the determination of catechol O-methyltransferase activity towards various substrates. J. Chromatogr. B 736 (1999) 143-151
6. Veltkamp A.C. Radiochromatography in pharmaceutical and biomedical analysis. J. Chromatogr. 531 (1990) 101-129
7. 14C-labeled glyceryl trinitrate and its metabolites by OPLC coupled with on-line or off-line radioactivity detection. J. Planar. Chromatogr. 15 (2002) 404-409
8. Egnash L.A., and Ramanathan R. Comparison of heterogeneous and homogeneous radioactivity flow detectors for simultaneous profiling and LC-MS/MS characterization of metabolites. J. Pharm. Biomed. Anal. 27 (2002) 271-284
9. Heath T.G., Mooney J.P., and Broersma R. Narrow-bore liquid chromatog-raphy-tandem mass spectrometry with simultaneous radioactivity monitoring for partially characterizing the biliary metabolites of an arginine fluoroalkyl ketone analog of D-MePhe-Pro-Arg, a potent thrombin inhibitor. J. Chromatogr. B 688 (1997) 281-289
10. Vlasakova V., Brezinova A., and Holik J. Study of cytokinin metabo-lism using HPLC with radioisotope detection. J. Pharm. Biomed. Anal. 17 (1998) 39-44
11. Onisko B.C. Radiochemical detection for packed capillary liquid chroma-tography-mass spectrometry. J. Am. Soc. Mass Spectrom. 13 (2001) 82-84
12. 14C-labelled flavonol metabolites by high-performance liquid chromatogra-phy-radiocounting and tandem mass spectrometry. J. Chromatogr. A 1007 (2003) 21-29
13. Morvovjan G.D., almadi-Kiss B., Klebovich I., and Mincsovice E. Metabo-lite analysis, isolation and purity assessment using various liquid Chromato-graphic techniques combined with radioactivity detection. J. Chromatogr. Sci. 40 (2002) 603-608
14. Iavarone L., Scandola M., Pugnaghi F., and Gross P. Qualitative analysis of potential metabolites and degradation products of a new antiinfective drug in rat urine, using HPLC with radiochemical detection and HPLC-mass spectrometry. J. Pharm. Biomed. Anal. 13 (1995) 607-614
15. Chando F.J., Everett D.W., Kahle A.D., Starrett A.M., Vachharajani N., Shyu W.C., Kripalani K.J., and Barbhaiya R.H. Biotransformation of irbestartan in man. Drug Metab. Dispos. 26 (1998) 408-417
16. Zhu M., Bering N., and Mitroka J.G. Use of HPLC with 96-well microplate scintillation counter for rapid profiling of low levels of radioactive metabolites in biological fluids. Drug Metab. Rev. 32 Suppl. 2 (2000) 177
17. Kelly P.J., Harrell A.W., North S.E., and Boyle G.W. A rapid and efficient method for off-line radiodetection using HPLC with TopCount and 96-well plate technology. Drug Metab. Rev. 32 Suppl. 2 (2000) 178
18. Boernsen K.O., Floeckher J.M., and Bruin G.J.M. Use of microplate scintil-lation counter as a radioactivity detector for miniaturized separation techniques in drug metabolism. Anal. Chem. 72 (2000) 3956-3959
19. Yin H., Greenberg G.E., and Fischer V. Application of Wallac MicroBeta radioactivity plate counter and Wallac Scintiplate in metabolite profiling and identification studies. Application Note. PerkinElmer Life Sciences (1900)
20. Kiffe M., Jehle A., and Ruembeli R. Combination of high performance liquid chromatography and microplate scintillation counting for crop and animal metabolism studies: a comparison with classical on-line and thin-layer chroma-tography radioactivity detection. Anal. Chem. 75 (2003) 723-730
21. Zhang D., Organ M., Gedamke R., Roongta V., Dai R., Zhu M., Rinehart J., Klunk L., and Mitroka J. Protein covalent binding of MaxiPost through a cytochrome P450-mediated ortho-quinone methoide intermediate in rats. Drug Metab. Dispos. 31 (2003) 837-845
22. Nedderman A.N.R., Savage M.E., White K.L., and Walder D.K. The use of 96-well scintiplates to facilitate definitive metabolism studies for drug candidates. J. Pharm. Biomed. Anal. 34 (2004) 607-617
23. Zhang D., Zhao W., Roongta V.A., Mitroka J.G., Klunk L.J., and Zhu M. Amide N-glucuronidation of MaxiPost catalyzed by UDP-glucuronosyltransferase 2B7 in humans. Drug Metab. Dispos. 32 (2004) 545-551
24. Zhu M., Zhao W., Jimenez H., Zhang D., Yeola S., Dai R., Vachharajani N., and Mitroka J. Cytochrome P4503A-mediated metabolism of buspirone in human liver microsomes. Drug Metab. Dispos. 33 (2005) 500-507
25. Zhu M., Zhang H., Zhao W., Mitroka J., and Klunk L. A novel in vitro approach, using a microplate scintillation counter and LC/MS, for determining formation pathways and structures of sequential metabolites: buspirone as an example. Drug Metab. Rev. 34 (2002) 167
26. Zhang H., Zhang D., and Ray K. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spec-trometric analyses. J. Mass Spectrom. 38 (2004) 1110-1112
27. Zhang H., Ray K., Zhao W., Zhang D., Gozo S., and Zhu M. A new approach utilizing mass defect filter on high resolution LC/MS data to identify metabolite ions in biological matrices: omeprazole as an example. ASMS Archive Abstract (2004)
28. Gedamke R., Zhao W., Gozo S., Mitroka J., and Zhu M. A sensitive method for plasma metabolite identification using nano LC/ion trap MS in conjunction with a microplate scintillation counter. ASMS Archive Abstract (2003)
29. Zhu M., Wang L., Gedamke R., Zhao W., Zhang D., and Gozo S. Determination of radioactivity distribution and metabolite profiles in tissues using a combination of microplate scintillation counting, capillary LC/MS and whole-body autoradiography. Metab. Rev. 35 (2003) 76
30. in press. Zhu M., Zhao W., Vazquez N., and Mitroka J.G. Analysis of low level radio- active metabolites in biological fluids using high-performance liquid chromatog- raphy with microplate scintillation counting: method validation and application. J. Pharm. Biomed. Anal. (2005)
31. TopCount NXT™ microplate scintillation & luminescence counters. Reference Manual (1999), Packard Instrument Company, Meriden, CT, USA
32. Currie L.A. Limits for qualitative detection and quantitative determination: application to radiochemistry. Anal. Chem. 40 (1968) 586-593
33. Nassar A.-E.F., Bjorge S.M., and Lee D.Y. On-line liquid chromatography-accurate radioisotope counting coupled with a radioactivity detector and mass spectrometer for metabolite identification in drug discovery and development. Anal. Chem. 75 (2003) 785-790
34. LSC Handbook of Environmental Liquid Scintillation Spectrometry (1996), Packard Instrument Company, Meriden, CT, USA
35. Clarke N.J., Rindgen D., Korfmacher W.A., and Cox K. Systematic LC/MS metabolite identification in drug discovery. Anal. Chem. 73 (2001) 431A-439A